THE CENTRE FOR TRANSLATIONAL CANCER RESEARCH PRESENTS

3rd Annual Immuno-Oncology Symposium

February 1, 2022 - 9:00am to 4:30pm EST

Register Here

 

 

Confirmed Speakers:

Patrick Hwu, MD - President and CEO, Moffitt Cancer Center (Florida). Tumor Immunologist, National Cancer Institute. Prior to joining Moffitt, internationally recognized tumor immunologist, Dr. Hwu was the head of the Division of Cancer Medicine at The University of Texas MD Anderson Center, Chairman of the Department of Melanoma Medical Oncology, Associate Director of the Center for Cancer Immunology Research and Chair of the Department of Sarcoma Medical Oncology. 

Williem J.M. Mulder, PhD  - Professor, Precision Medicine at Eindhoven University of Technology,  Department of Biomedical Engineering. Professor, Radiology and Ocological Sciences and Director, Nanomedicine Program, Icahn School of Medicine, Mount Sinai (NY). 

Pamela Ohashi, PhD - Director, Immune Therapy Program and Senior Scientist, Ontario Cancer Institute, Princess Margaret Cancer Centre, University Health Network. Co-Director, Campbell Family Institute for Breast Cancer Research. Professor, Department of Medical Biophysics, University of Toronto. Canada Research Chair, Autoimmunity and Tumour Immunity. 

Padmanee Sharma, MD. PhD - Professor, Department of Genitourinary Medical Oncology, and Immunology, Division of Cancer Medicine, MD Anderson Cancer Center. Scientific Director, Immunotherapy Platform, MD Anderson Cancer Center.

Jennifer Wargo, MD. M.M.Sc - Professor, Department of Genomic Medicine, Division of Cancer Medicine and Department of Surgical Oncology, The University of Texas. Division of Surgery, MD Anderson Cancer Centre. 

Anna Wu, PhD - Chair and Professor, Department of Immunology & Theranostics, and Professor, Department of Radiation Oncology, Beckman Research Institute of City of Hope. Co-Director, Center for Theranostic Studies, City of Hope (Duarte, California). Research Professor, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA. 

 

Confirmed Industry Speakers: 

Naoto Hirano, MD. PhD - Associate Director for Research, Tumor Immmunotherapy Program, and Senior Scientist, Princess Margaret Cancer Centre, University Health Network. Professor, Department of Immunology, University of Toronto. Senior Investigator, Ontario Institute of Cancer Research. Investigator, BioCanRx.   

Jelena Levi, PhD - Chief Scientific Officer - CellSight Technologies. Dr. Jelena Levi has over 15 years of experience in the field of molecular imaging. Prior to CellSight Technologist, Jelena served as Director of Chemistry Core at Canary Center for Early Cancer Detection at Stanford University. Her research focuses on development of targeted imaging agents that can be used in cancer diagnosis and treatment monitoring. 

Erica Stone, PhD - VP, Oncology - GigaGen Inc. Dr. Erica Stone is an award-winning immunologist with expertise in T cell immunology, immuno-oncology and human immunology. At GigaGen, Dr. Stone leads immuno-oncology research and discovery of new first-in-class antibody therapies. Dr. Stone was recently Assistant Professor in the Immunology, Microenvironment and Metastasis Program at The Wistar Institute Cancer Center. 

Organizing Committee Members:

                          

Saman Maleki, PhD. Conference Chair - Assistant Professor, Departments of Oncology, and Pathology and Laboratory Medicine, and Medical Biophysics. Schulich School of Medicine & Dentistry, Western University. Principal Scientist, Lawson Health Research Institute. 

Glenn Bauman, MD. FRCPC - Distinguised Professor, Departments of Oncology, and Medical Biophysics. Schulich School of Medicine & Dentistry, Western University. Radiation Oncologist, London Regional Cancer Program, London Health Sciences Centre. Associate Scientist, Lawson Health Research Institute. 

Gabriel DiMattia, PhD - Interim Director, Cancer Research Laboratory Program, London Regional Cancer Program. Associate Professor, Departments of Oncology, and Biochemistry, Schulich School of Medicine & Dentistry, Western University. Senior Oncology Scientist, Lawson Health Research Institute. 

Joe Mymryk, PhD - Professor, Departments of Oncology, and Microbiology & Immunology, and Otolaryngology, Schulich School of Medicine & Dentistry, Western University. Distingushed Oncology Scientist, Cancer Research Laboratory Program, London Regional Cancer Program. Scientist, Lawson Health Research Institute. 

John Ronald, PhD - Associate Professor, Department of Medical Biophysics, Schulich School of Medicine & Dentistry, Western University. Scientist, Robarts Research Institute. 

Kimberly Scott, Conference Coordinator - Coordinator for the Centre for Translational Cancer Research,  London Regional Cancer Program Wellness, and Resiliency Task Force Coordinator, and Oncology Grand Rounds Coordinator.